Osteoporosis Highlights From WCO-IOF-ESCEO 2021

Olivier Bruyère, PhD


September 16, 2021

Prof Olivier Bruyère of the University of Liège, Belgium, offers insight on key findings in osteoporosis, presented at the 2021 WCO-IOF-ESCEO Virtual Congress.

First, Prof Bruyère discusses a study looking at patient preferences for lifestyle changes in osteoporotic fracture prevention and how the results differed among seven European countries.

Next, he reviews a UK study that found that better bone health is associated with better vascular health, and that management of one disorder could have an impact on the other.

Prof Bruyère then highlights a study that assesses the prevalence of older adults at high risk for fracture who are not on preventive medication. Of the high-risk patients, more than 95% were not taking any osteoporosis medication.

Finally, Prof Bruyère reviews data about the use of oral NSAIDs and the interaction with clodronates, a bisphosphonate that reduces the risk for fracture. The study authors found that NSAID use was associated with increased risk for osteoporotic fracture and that it may affect the efficacy of bisphosphonate therapy.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.